Clinical Trial: Safety and Efficacy of OBX-115 in Advanced/Metastatic Melanoma Resistant to Immune Checkpoint Inhibitors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Tumor Skin
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Open-Label Study to Investigate the Safety and Efficacy of Membrane Bound IL15 Expressing Tumor-Infiltrating Lymphocytes (OBX-115) In Participants With Unresectable or Metastatic Mel
Brief Summary:
This is a study to investigate the safety and efficacy of an investigational regimen, OBX-115, in adult participants with advanced/metastatic melanoma.
Read more